Tuberculosis (TB) news, resources and funding for global health researchers
A major cause of death and disability worldwide, tuberculosis is a contagious lung disease that spreads through the air when people infected with it cough, sneeze, talk or spit. TB is caused by a bacterium called
Mycobacterium tuberculosis, which usually attacks the lungs, but can affect other parts of the body like the kidney, spine and brain. The disease can be fatal if not treated properly.
According to the World Health Organization, there are almost 2 million TB-related deaths each year, and more than 9 million people around the world become sick with the disease annually. In 2009, almost 10 million children were orphaned as a result of parental deaths caused by TB. The spread of multidrug-resistant TB is a growing global threat, with hundreds of thousands of new cases emerging each year.
TB coinfection with HIV/AIDS is also a serious health issue and a leading cause of death worldwide among people with HIV. Several NIH research and research training programs are helping to reduce the impact of tuberculosis both in the U.S. and overseas.
Grant Awards Related to TB
Recent News
- WHO announces plans to establish a TB Vaccine Accelerator council
WHO news, January 17, 2023
-
Tuberculosis deaths and disease increase during the COVID-19 pandemic
WHO news, October 27, 2022
-
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis, co-authored by Fogarty trainees Lali Mikiashvili and Ebrahim Variava
New England Journal of Medicine, September 1, 2022 -
Accuracy of Tongue Swab Testing Using Xpert MTB-RIF Ultra for Tuberculosis Diagnosis, co-authored by Fogarty trainees Alfred Andama and William Worodria
Journal of Clinical Microbiology, July 20, 2022 -
Developing customized stepwise MIRU-VNTR typing for tuberculosis surveillance in Georgia
co-authored by Fogarty grantees Drs. Nestani Tukvadze and Henry Blumberg
PLoS One, March 1, 2022
-
Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study, Fogarty grantee Sean Wasserman lead author
Journal of Antimicrobial Chemotherapy, February 2, 2022 -
Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gaps, Fogarty grantee Anushka Naidoo lead author
Lancet HIV, February 1, 2022 -
Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low- and Middle-Income Countries, Fogarty grantee Karen du Preez lead author
Pathogens, February 1, 2022 -
Perspective: Covid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery
co-authored by Fogarty trainees Dr. Madhukar Pai and Dr. Soumya Swaminathan
New England Journal of Medicine, January 5, 2022 -
Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic
WHO news release, October 14, 2021
-
Landmark [international] TB trial identifies shorter-course treatment regimen
NIAID/NIH news, October 21, 2020
-
New research tool supports scale-up of digital technologies to end TB
TDR news, March 24, 2020 -
Recent advances in addressing tuberculosis give hope for future
NIAID/NIH news, February 11, 2020
Related Fogarty News and Information
NIH News and Resources
Other US Government Resources
- Centers for Disease Control and Prevention (CDC):
- U.S. Agency for International Development (USAID):Tuberculosis
Other Online Resources
Updated January 18, 2023